OmniAb, Inc.·4

Feb 18, 6:35 PM ET

GUSTAFSON KURT A 4

4 · OmniAb, Inc. · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

OmniAb (OABI) CFO Kurt Gustafson Receives RSUs, Sells Shares

What Happened Kurt A. Gustafson, OmniAb's Executive VP, Finance and CFO, reported multiple equity transactions on 2026-02-18. He acquired (via award) 60,000 RSUs and 600,000 RSUs (total 660,000 RSUs, each representing a contingent right to one share). He also exercised/converted derivative awards for 18,750 shares (reported at $0.00). To satisfy tax withholding related to RSU vesting, 9,301 shares were sold in the open market at a weighted average price of $1.71, generating approximately $15,905. The filing shows both an acquisition and a corresponding derivative disposition of 18,750 shares (see footnotes for vesting/settlement details).

Key Details

  • Transaction date: February 18, 2026 (Form 4 filed same day).
  • Open-market sale: 9,301 shares at a weighted average price $1.71, total ≈ $15,905 (sales ranged $1.68–$1.73; reporting person can provide per-price breakdown) (Footnotes F3, F4).
  • Awards granted: 60,000 RSUs and 600,000 RSUs (each RSU = one contingent share) reported as acquired at $0.00 (Footnotes F2, F1, F5 describe vesting schedules).
  • Option/derivative activity: Exercise/conversion reported for 18,750 shares (M code) and a matching derivative disposition of 18,750 shares at $0.00; see Footnote F6 for option vesting/exercisability schedule.
  • Sell-to-cover: The 9,301-share sale was mandated to satisfy tax withholding on RSU vesting, not a discretionary sale by the insider (Footnote F3).
  • Shares owned after the transactions: not specified in the provided filing excerpt.
  • Timeliness: Filing date equals transaction date — appears timely (no late filing indicated).

Context

  • The large items here are awards (RSUs) and an option/derivative conversion — these are grant/vesting and exercise events, not straightforward open-market purchases. The only open-market sale was a sell-to-cover to meet tax obligations and is described as mandated by the company’s equity plan (not an independent judgmental sale).
  • For retail investors: awards and option exercises are common executive compensation events. Sell-to-cover sales typically do not signal a personal decision to reduce holdings.

Insider Transaction Report

Form 4
Period: 2026-02-18
GUSTAFSON KURT A
Executive VP, Finance and CFO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-02-18+18,750278,152 total
  • Sale

    Common Stock

    [F3][F4]
    2026-02-18$1.71/sh9,301$15,905268,851 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F1]
    2026-02-1818,75064,584 total
    Exercise: $0.00Common Stock (18,750 underlying)
  • Award

    Restricted Stock Units

    [F2][F5]
    2026-02-18+60,000124,584 total
    Exercise: $0.00Common Stock (60,000 underlying)
  • Award

    Stock Option

    [F6]
    2026-02-18+600,000600,000 total
    Exercise: $1.71Exp: 2036-02-18Common Stock (600,000 underlying)
Footnotes (6)
  • [F1]Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 18, 2026
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.68 to $1.73. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The RSU grant vests in three substantially equal annual installments beginning on February 18, 2027.
  • [F6]The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.
Signature
By: /s/ Charles S. Berkman, Attorney-in-Fact For: Kurt A. Gustafson|2026-02-18

Documents

1 file
  • 4
    wk-form4_1771457726.xmlPrimary

    FORM 4